Previous studies have reported that mid infrared light treatment could ameliorate the cognitive deficits of APP/PS1 mice, a transgenic AD mouse model, via regulating gut microbiota, and enhancing the microglial phagocytosis to clean Aβ deposition (Li et al., 2022; Wang et al., 2020). The gene discussed is APP; the disease is Alzheimer disease.